Molecular Basis of Cell Membrane Estrogen Receptor Interaction With Phosphatidylinositol 3-Kinase in Endothelial Cells

Objective—Nontranscriptional signaling mechanisms mediate some of the biological effects of estrogen, such as the rapid actions on the blood vessels. By interacting with phosphatidylinositol 3-kinase (PI3K), estrogen receptor (ER) &agr; leads to activation of protein kinase Akt and to subsequent increase in endothelial nitric oxide synthase activity. Because PI3K is mainly a cytoplasmic complex, we studied the cellular site of interaction between this enzyme and ER&agr;, and we dissected the molecular mechanisms that mediate this interaction. Methods and Results—By using cultured human saphenous vain endothelial cells, we found that cell membrane–bound ER&agr; colocalizes with PI3K and may be responsible for PI3K activation. Furthermore, we characterized the subsequent steps in the activation of the PI3K/Akt signaling cascade, comparing the molecular events that follow insulin or estradiol activation of PI3K. Conclusions—We provide novel evidence for an important role of nonnuclear estrogen receptor in rapid, nontranscriptional responses of human endothelial cells to estrogen.

[1]  P. Shaul,et al.  Estrogen modulation of endothelial nitric oxide synthase. , 2002, Endocrine reviews.

[2]  R. Karas,et al.  The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.

[3]  P. Chambon,et al.  Estrogen Receptor-&agr; Mediates the Protective Effects of Estrogen Against Vascular Injury , 2002, Circulation research.

[4]  M. Moskowitz,et al.  Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase , 2002, Nature Medicine.

[5]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[6]  K. Ley,et al.  Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase , 2000, Nature.

[7]  R. de Caterina,et al.  Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. , 2000, Circulation research.

[8]  T. Simoncini,et al.  Direct vascular effects of estrogens and selective estrogen receptor modulators , 2000, Current opinion in obstetrics & gynecology.

[9]  J. Bender,et al.  Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Fricchione,et al.  Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. , 2000, Circulation.

[11]  J. Gustafsson.  Novel Aspects of Estrogen Action , 2000, The Journal of the Society for Gynecologic Investigation: JSGI.

[12]  E. Levin.  Cellular Functions of the Plasma Membrane Estrogen Receptor , 1999, Trends in Endocrinology & Metabolism.

[13]  R. Busse,et al.  Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation , 1999, Nature.

[14]  W. Sessa,et al.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt , 1999, Nature.

[15]  Lewis C. Cantley,et al.  The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function* , 1999, The Journal of Biological Chemistry.

[16]  R. Karas,et al.  Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. , 1999, The Journal of clinical investigation.

[17]  G. Greene,et al.  Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. , 1999, Molecular endocrinology.

[18]  J. Woodgett,et al.  Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Gustafsson,et al.  Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. , 1998, Circulation research.

[20]  F. McCormick,et al.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[21]  A. Quyyumi,et al.  The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. , 1997, Circulation.

[22]  M. Lieberherr,et al.  Phospholipase C β and Membrane Action of Calcitriol and Estradiol* , 1997, The Journal of Biological Chemistry.

[23]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[24]  M. Quon,et al.  Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. , 1996, The Journal of clinical investigation.

[25]  L. Cantley,et al.  Phosphoinositide 3-kinase and the regulation of cell growth. , 1996, Biochimica et biophysica acta.

[26]  P. Bontempo,et al.  Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells. , 1996, The EMBO journal.

[27]  Toshio Kitazawa,et al.  17β-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells , 1995 .

[28]  R. White,et al.  Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. , 1995, Circulation research.

[29]  Andrius Kazlauskas,et al.  The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.

[30]  B. Katzenellenbogen,et al.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Walsh,et al.  Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Cantley,et al.  Purification and characterization of phosphoinositide 3-kinase from rat liver. , 1990, The Journal of biological chemistry.

[33]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[34]  P. Libby,et al.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.

[35]  W. Rutter,et al.  Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. , 1985, Science.

[36]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[37]  R. Pietras,et al.  Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells , 1977, Nature.

[38]  M. Omata,et al.  17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. , 1995, European journal of pharmacology.